SHERLOCK diagnostic technology
GPTKB entity
Statements (26)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
diagnostic technology
|
| gptkbp:application |
infectious disease detection
genetic mutation detection |
| gptkbp:commercialUse |
gptkb:Sherlock_Biosciences
|
| gptkbp:detects |
gptkb:COVID-19
gptkb:Zika_virus gptkb:Dengue_virus nucleic acids antibiotic resistance genes |
| gptkbp:developedBy |
gptkb:Broad_Institute
|
| gptkbp:firstPublished |
2017
|
| gptkbp:fullName |
gptkb:Specific_High-sensitivity_Enzymatic_Reporter_unLOCKing
|
| https://www.w3.org/2000/01/rdf-schema#label |
SHERLOCK diagnostic technology
|
| gptkbp:inventedBy |
gptkb:Feng_Zhang
gptkb:James_Collins gptkb:Jonathan_Gootenberg gptkb:Omar_Abudayyeh |
| gptkbp:method |
isothermal amplification
CRISPR-mediated detection |
| gptkbp:notableFor |
high sensitivity
rapid results point-of-care use |
| gptkbp:relatedTo |
DETECTR diagnostic technology
|
| gptkbp:uses |
gptkb:CRISPR-Cas13
|
| gptkbp:bfsParent |
gptkb:Omar_Abudayyeh
|
| gptkbp:bfsLayer |
7
|